​

TAO Synergies Stock (NASDAQ:TAOX)

FinancialsChart
TAO Synergies by TradingView

Previous Close

$3.76

52W Range

$1.84 - $11.98

50D Avg

$4.69

200D Avg

$5.89

Market Cap

$13.60M

Avg Vol (3M)

$164.10K

Beta

2.02

Div Yield

-

TAOX Company Profile

Clinical-stage biopharmaceutical company developing a bryostatin‑1 platform for Alzheimer’s and other neurodegenerative/cognitive diseases. Also pivoting to a digital-asset treasury strategy focused on acquiring and staking TAO cryptocurrency.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

4

IPO Date

Jul 02, 2025

Website

TAOX Performance

TAOX Financial Summary

Dec 24Dec 23Dec 22
Revenue---
Operating Income---
Net Income$-12.77M$-6.04M$-5.57M
EBITDA$-6.81M$-8.31M$-16.13M
Basic EPS-$-29.56$-20.25
Diluted EPS-$-29.56$-20.25

Fiscal year ends in Dec 24 | Currency in USD

Peer Comparison

TickerCompany
INTSIntensity Therapeutics, Inc.
IBIOiBio, Inc.
RLYBRallybio Corporation
KLTOKlotho Neurosciences, Inc.
NXTCNextCure, Inc.
CVKDCadrenal Therapeutics, Inc. Common Stock
BOLDBoundless Bio, Inc.
SONNSonnet BioTherapeutics Holdings, Inc.
ITRMIterum Therapeutics plc
PSTVPlus Therapeutics, Inc.